Zobrazeno 1 - 10
of 53
pro vyhledávání: '"S. Zingarelli"'
Autor:
C. Biasini Rebaioli, M. Vianelli, M. Nuzzo, T. Ziglioli, S. Zingarelli, C. Bazzani, M. Filippini, R. Cattaneo, R. Gorla
Publikováno v:
Reumatismo, Vol 60, Iss 1, Pp 41-49 (2011)
Objective: To evaluate the efficacy and the safety of anti-TNF-alfa treatment in elderly patients (≥65 years old) with active rheumatoid arthritis (RA), in comparison with younger (17-65 years old). Methods: We considered retrospectively 295 patien
Externí odkaz:
https://doaj.org/article/2dd11d73367c4688b0c0b02b4fe09865
Publikováno v:
Reumatismo, Vol 60, Iss 1, Pp 22-27 (2011)
Hepatitis B virus (HBV) is a DNA virus transmitted predominantly by sexual contact or percutaneous exposure. HBV infection is by far the most common chronic viral infection affecting the liver in the world, and a leading cause of cirrhosis and hepato
Externí odkaz:
https://doaj.org/article/5032d7e4cc4c4e4e84757d3d4d6bab87
Publikováno v:
Reumatismo, Vol 60, Iss 2, Pp 131-135 (2011)
Objectives: To investigate whether the aggressive use of DMARDs can control the clinical disease in the early arthritis, to define new parameters of the disease aggressivity and to study the effectiveness of RMN in comparison with RX focusing on the
Externí odkaz:
https://doaj.org/article/d7f0a0295ae14d4b8aa1cbf2b4ab2e1d
Autor:
R. Cattaneo, R. Caporali, A. Ceribelli, S. Zingarelli, E. Bravi, C. Bazzani, F. Bobbio-Pallavicini, I. Cavazzana, F. Franceschini, C. Montecucco
Publikováno v:
Reumatismo, Vol 58, Iss 4, Pp 275-282 (2011)
Objective: to analyse efficacy and safety of anti-TNFa treatment in 17 patients with rheumatoid arthritis (AR) and anti- Ro antibodies, in order to detect difference in clinical and immunological response. Methods: 322 patients, affected by RA and tr
Externí odkaz:
https://doaj.org/article/9b2ce458651b42d497ae49690b708dc7
Autor:
Vanessa Smith, Jeska K de Vries-Bouwstra, Yannick Allanore, Francesca Ingegnoli, Simone Barsotti, Roger Hesselstrand, Franco Franceschini, S. Zingarelli, Giacomo De Luca, Marie-Elise Truchetet, Eric Hachulla, Ellen De Langhe, Paolo Airò, Elisabetta Zanatta, Maria Grazia Lazzaroni, Angela Ceribelli, Silvia Bellando Randone, Cristian Caimmi, Enrico Colombo
Publikováno v:
Scleroderma, myositis and related syndromes.
Background The main clinical associations of anti-PM/Scl in Systemic Sclerosis (SSc) include calcinosis, joint and muscle involvement, interstitial lung disease (ILD), and, possibly, scleroderma renal crisis (1,2). A possible association of anti-PM/S
Publikováno v:
Annals of the Rheumatic Diseases. 79:407.1-407
Background:Anti-PM/Scl antibodies positivity has been associated with frequent skeletal muscle involvement in patients with Systemic Sclerosis (SSc) in different studies, including the EUSTAR cohort (1). Moreover, although myositis has been previousl
Autor:
M.G. Fenini, Roberto Furloni, A. Premoli, M. G. Lazzaroni, Mirko Scarsi, F. Inverardi, Francesca Dall'Ara, Paolo Airò, Angela Tincani, S. Zingarelli
Publikováno v:
Saturday, 16 JUNE 2018.
Background Not much information is available on the variations in the incidence and prevalence of Systemic Sclerosis (SSc) over time. Objectives To investigate the epidemiology of SSc in Valcamonica, an Alpine valley in northern Italy (Brescia Provin
Autor:
Eric Hachulla, A. Furloni, Yannick Allanore, Ilaria Cavazzana, Silvia Bellando-Randone, Angela Tincani, Cristian Caimmi, Franco Franceschini, S. Zingarelli, M. G. Lazzaroni, Paolo Airò
Publikováno v:
THURSDAY, 14 JUNE 2018.
Background Antibodies to the PM/Scl complex are found in patients with Systemic Sclerosis (SSc), but also with Polymyositis, Dermatomyositis and overlap syndromes. Historically, the main clinical association of anti-PM/Scl antibodies in SSc, which in
Publikováno v:
The Journal of Rheumatology. 36:1188-1194
Objective.To evaluate the development of hepatitis B virus (HBV) infection in patients receiving tumor necrosis factor-α-blocking agents (TNFBA), and to evaluate whether lamivudine (LAM) prophylaxis can reduce the risk of viral reactivation in inact
Autor:
Roberto Caporali, Roberto Cattaneo, Angela Ceribelli, Chiara Bazzani, Ilaria Cavazzana, S. Zingarelli, E. Bravi, Francesca Bobbio-Pallavicini, Franco Franceschini, Carlomaurizio Montecucco
Publikováno v:
Reumatismo, Vol 58, Iss 4, Pp 275-282 (2011)
Objective: to analyse efficacy and safety of anti-TNFa treatment in 17 patients with rheumatoid arthritis (AR) and anti- Ro antibodies, in order to detect difference in clinical and immunological response. Methods: 322 patients, affected by RA and tr